منابع اگزون ۳۲
انجمن زیستشناسی سلولی و مولکولی دانشگاه تبریزگزارش:
اخبار:
1.https://www.sciencedaily.com/releases/2024/02/240202115141.htm
Hussain, W., Mahmood, T., Hussain, J., Ali, N., Shah, T., Qayyum, S., & Khan, I. (2019).
2.CRISPR/Cas system: a game changing genome editing technology, to treat human genetic
diseases. Gene, 685, 70-75.
3. Kan, M. J., & Doudna, J. A. (2022). Treatment of genetic diseases with CRISPR genome
editing. Jama, 328(10), 980-981.
4. Khan, F. A., Pandupuspitasari, N. S., Chun-Jie, H., Ao, Z., Jamal, M., Zohaib, A., ... & ShuJun,
Z. (2016). CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseases.
Oncotarget, 7(32), 52541.
5. Abdelnour, S. A., Xie, L., Hassanin, A. A., Zuo, E., & Lu, Y. (2021). The potential
of CRISPR/Cas9 gene editing as a treatment strategy for inherited diseases.
Frontiers in cell and developmental biology, 9, 699597.
بیودیپ:
https://www.genengnews.com/topics/genome-editing/print-precise-rna-mediated-insertion-of-transgenes/
📘